Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

FORCE REPAIR

Financiado

Cerrado

smart and multiFunctional 3D printable prO Regenerative biologiCal matrix modula...

smart and multiFunctional 3D printable prO Regenerative biologiCal matrix modulating mEchanotRansduction as advancEd theraPy to treAt skIn chRonic wounds Due to population lifestyle changes, i.e. obesity, diabetes and aging population, chronic wounds (CW) which fail to follow the typical healing process is a major medical socioeconomic challenge. Current wound management is clearly... ver más

31/12/2026

CIDETEC

5M€

Presupuesto del proyecto: 5M€

Líder del proyecto

FUNDACION CIDETEC No se ha especificado una descripción o un objeto social para esta compañía.

TRL 2-3 | 14M€

Fecha límite participación Sin fecha límite de participación.

Ver 17 Participantes

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2022-11-18

HORIZON-CL4-2022-RESILIENCE-01-13: Smart and multifunctional biomateri... ExpectedOutcome:Multi-functional biomaterials are capable, by virtue of their own material ingredien...

I+D

Cerrada hace 2 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

17 Participantes

CIDETEC

868.75K€ | Lider

Bordeaux INP

37.25K€ | Participante

RESEARCH AND INNOVATION SERV...

163.75K€ | Participante

ASPHALION

176.25K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

HEXKIN Healing Exosomes for sKIN 71K€ Cerrado

MULTIZONAL SCAFFOLD Multizonal scaffold system based on collagen and copper dope... 171K€ Cerrado

VascColl Temporally controlled delivery of vascular therapeutics from... 188K€ Cerrado

PID2020-117900RB-I00 NUEVOS APOSITOS BASADOS EN NANOFIBRAS DE VIDRIO BIOACTIVO PR... 132K€ Cerrado

PCI2019-103648 MATERIALES LIBERADORES DE IONES PARA PROMOVER LA ANGIOGENESI... 190K€ Cerrado

RTI2018-095490-J-I00 NUEVOS APOSITOS BASADOS EN NANOFIBRAS DE VIDRIO BIOACTIVO PR... 157K€ Cerrado

Duración del proyecto: 49 meses Fecha Inicio: 2022-11-18
Fecha Fin: 2026-12-31

Líder del proyecto

FUNDACION CIDETEC No se ha especificado una descripción o un objeto social para esta compañía.

TRL 2-3 | 14M€

Presupuesto del proyecto 5M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Due to population lifestyle changes, i.e. obesity, diabetes and aging population, chronic wounds (CW) which fail to follow the typical healing process is a major medical socioeconomic challenge. Current wound management is clearly insufficient and advanced therapies failed in keeping their promise of reliable skin regeneration. The aim of FORCE REPAIR is to develop a smart and multifunctional wound dressing providing pro-regenerative environment and mechanical stability to treat CW. Thus, FORCE REPAIR will combine state-of-the-art technologies in a biological scaffold tailored to patient’s needs: (1) Antibacterial and bioadhesive bioink with antibiotics and anti-inflammatory loaded nanocapsules, (2) Elastin like polypeptides promoting innervation and vascularization (3) Wharton Gel Complex preventing oxidative stress and boosting key extracellular matrix proteins. Also, the dressing activated by UV light will induce contractile force to help wound closure and activate skin regeneration. A customized 3D bioprinter with a user-friendly 3D trajectory software will help to strategically placed the biological compounds to timely address and mitigate the degenerative process occurring in CW, i.e. infection, inflammation, tension forces to promote skin regeneration. The 3D printed dressing will be tested in relevant in vitro model with a human exudate library and testing relevant key healing steps (i.e. re-epithelization, angiogenesis, cell proliferation…). Selected candidates will be tested in vivo on pig CW models and mice with bacterial infection. To ensure translation to clinical practice and reach patients, regulatory framework, HTA and a business model will be defined for a viable exploitation strategy that will decrease economic burden of wound care management and improve patients’ QoL. Finally, to ensure market acceptance health professional will guide the development of FORCE REPAIR to offer a dressing that treat efficiently CW and can be used by medical staff.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores